Combining TGF-β1 knockdown and miR200c administration to optimize antitumor efficacy of B16F10/GPI-IL-21 vaccine | |
Wang, Xiaoying/55969559500[0]; Zhao, Fengshu/12793778800[1]; He, Xiangfeng/35277232800[2]; Wang, Jing/56042374500[3]; Zhang, Ying/55613583979[4]; Zhang, Hongyi/45461531800[5]; Ni, Yaoyao/56659008100[6]; Sun, Jianan/56606445800[7]; Wang, Xiaobing/57192627005[8]; Dou, Jun/8852232200[9] | |
刊名 | Oncotarget |
2015 | |
卷号 | 6期号:14 |
关键词 | Interleukin-21 Melanoma MiR200c Transforming growth factor β1 Tumor vaccine |
ISSN号 | 1949-2553 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4874691 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Wang, Xiaoying/55969559500[0],Zhao, Fengshu/12793778800[1],He, Xiangfeng/35277232800[2],et al. Combining TGF-β1 knockdown and miR200c administration to optimize antitumor efficacy of B16F10/GPI-IL-21 vaccine[J]. Oncotarget,2015,6(14). |
APA | Wang, Xiaoying/55969559500[0].,Zhao, Fengshu/12793778800[1].,He, Xiangfeng/35277232800[2].,Wang, Jing/56042374500[3].,Zhang, Ying/55613583979[4].,...&Dou, Jun/8852232200[9].(2015).Combining TGF-β1 knockdown and miR200c administration to optimize antitumor efficacy of B16F10/GPI-IL-21 vaccine.Oncotarget,6(14). |
MLA | Wang, Xiaoying/55969559500[0],et al."Combining TGF-β1 knockdown and miR200c administration to optimize antitumor efficacy of B16F10/GPI-IL-21 vaccine".Oncotarget 6.14(2015). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论